Skip to main content
. Author manuscript; available in PMC: 2013 Mar 7.
Published in final edited form as: Clin Neuropsychol. 2012 Mar 7;26(2):288–304. doi: 10.1080/13854046.2011.653404

Table 1.

Demographic, HIV Disease, and Psychiatric Characteristics of Study Participants (n=186)

Participant characteristic HIV− (n = 43) HIV+ HAND− (n = 103) HIV+ HAND+ (n = 40) p Pairwise comparisons
Demographic
 Age (years) 43.3 (12.5) 45.6 (8.2) 45.1 (9.2) .6141 -
 Education (years) 14.6 (2.2) 14.1 (2.2) 14.1 (2.6) .4050 -
 Sex (% men) 53.5% 89.3% 82.5% <. 0001** HIV− < HAND− = HAND+
 Ethnicity (% Caucasian) 53.5% 63.1% 55.0% .2423 -
 Est. verbal IQa 105.7 (11.2) 107.1 (11.0) 99.6 (12.8) .0042* HIV− = HAND− > HAND+
HIV Disease
 Est. duration of infection (years) - 16.1 (7.1, 20.6) 10.6 (6.9, 21.8) .4174 -
 Current CD4 Count - 525.5 (318.5, 751.0) 566.5 (372.8, 931.0) .1475 -
 Nadir CD4 Count - 140.0 (35.0, 288.0) 185.5 (50.5, 357.5) .5542 -
 HIV RNA plasma (log10) - 1.7 (1.7, 2.2) 1.7 (1.7, 2.7) .7755 -
 AIDS (%) - 64.0% 55.0% .3166 -
 Proportion on HAART - 82.5% 72.5% .0839 -
Psychiatric Characteristics
 Substance dependence (lifetime) 35.7% 50.5% 55.3% .1656 -
 Major depressive disorder (lifetime) 35.7% 50.5% 60.5% .0791 -
 Generalized anxiety disorder (lifetime) 7.1% 3.8% 10.5% .3393 -
 POMS Total mood disturbance 45.05 (28.54) 64.76 (37.59) 51.58 (33.41) .0421* HIV− = HAND− < HAND+

Note.

a

as measured by the WTAR. HAART = highly active antiretroviral therapy. POMS = Profile of Mood States.

*

p < .05,

**

p < .001.